Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
| Fiscal year / year | Quanterix revenue |
|---|---|
| 2016 | $17.6M |
| 2017 | $22.9M |
| 2018 | $37.6M |
| 2019 | $56.7M |
| 2020 | $86.4M |
| 2021 | $110.6M |
| 2022 | $105.5M |
| 2023 | $122.4M |
| 2024 | $137.4M |
How accurately did Quanterix's revenue projections match actual performance?
Quanterix saw the greatest revenue growth in 2018, when revenue increased by 64.52%.
Quanterix had the lowest revenue growth in 2022, when revenue changed by -4.55%.
| Year | Quanterix growth |
|---|---|
| 2017 | 30%↑ |
| 2018 | 65%↑ |
| 2019 | 51%↑ |
| 2020 | 52%↑ |
| 2021 | 28%↑ |
| 2022 | -5%↓ |
| 2023 | 16%↑ |
| 2024 | 12%↑ |
Do you work at Quanterix?
Is Quanterix transparent about its revenue structure?
| CEO | E. Kevin Hrusovsky |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 177 |
| Date Founded | 2007 |
| Headquarters | Billerica, Massachusetts |
| Revenue | $137.4M |
| Net Income | -$96,700,000 |
| Gross Proft | $83.1M (2024) |
| Tax Rate | -0.0% |
| Total Assets | $434,199,000 |
| Ticker | QTRX |
Quanterix received early financing of $15.0M on 2008-08-25.
| Series | Round size | Date |
|---|---|---|
| Series A | $15M | 08/2008 |
| Series Unknown | $2.5M | 10/2010 |
| Series B | $6M | 08/2011 |
| Debt Financing | $2.0M | 03/2012 |
| Series C | $18.5M | 11/2012 |
| Series D | $46M | 03/2016 |
| Series D | $8.5M | 08/2017 |
| Post Ipo Equity | $49.7M | 10/2019 |
| Post Ipo Equity | $97.6M | 08/2020 |
| Post Ipo Equity | $287.5M | 02/2021 |
| Investors | Security type |
|---|---|
| Bain Capital Ventures | Series A |
| ARCH Venture Partners | Series A |
| Flagship Pioneering Inc | Series A |
| In-Q-Tel | Series B |
| bioMérieux SA | Series C |
| Bain Capital Ventures | Series C |
| ARCH Venture Partners | Series C |
| In-Q-Tel | Series C |
| Flagship Pioneering Inc | Series C |
| Bain Capital Ventures | Series D |
| Tufts University | Series D |
| Cormorant Asset Management | Series D |
| Trinitas Capital | Series D |
| ARCH Venture Partners | Series D |
| ARCH Overage Fund | Series D |
| HERCULES CAPITAL INC | Series D |
| T. Rowe Price | Series D |
Quanterix's top competitor, Philips Healthcare, earned an annual revenue of $6.8B.
Quanterix's smallest competitor is Singulex with revenue of $930.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Pacific Biomarkers | $78,220 | $6.1M | 125 | - |
| Bio-Techne | $60,214 | $1.2B | 2,250 | 143 |
| Singulex | $45,617 | $930,000 | 50 | - |
| Banyan Biomarkers | $47,142 | $8.0M | 23 | - |
| Caliper Life Sciences | $81,030 | $109.8M | 200 | - |
| PacBio | $93,409 | $154.0M | 400 | 15 |
| Agilent Technologies | $88,186 | $6.5B | 13,500 | 187 |
| AgaMatrix | $89,414 | $29.5M | 115 | - |
| Illumina | $94,044 | $4.4B | 7,800 | 123 |
| Philips Healthcare | $85,358 | $6.8B | 24,000 | 168 |
Zippia gives an in-depth look into the details of Quanterix, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Quanterix. The employee data is based on information from people who have self-reported their past or current employments at Quanterix. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Quanterix. The data presented on this page does not represent the view of Quanterix and its employees or that of Zippia.
Quanterix may also be known as or be related to QUANTERIX, QUANTERIX CORP, Quanterix, Quanterix Corp, Quanterix Corp. and Quanterix Corporation.